Mettler-Toledo International, Inc. (NYSE:MTD) Given Average Rating of “Hold” by Brokerages

Shares of Mettler-Toledo International, Inc. (NYSE:MTD) have received an average rating of “Hold” from the thirteen research firms that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $1,441.6667.

MTD has been the topic of several recent analyst reports. Barclays dropped their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Mettler-Toledo International in a research note on Monday, December 29th. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research report on Monday, January 19th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective on the stock. Finally, Evercore ISI lifted their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th.

Insider Buying and Selling

In other news, insider La Guerroniere Marc De sold 6,055 shares of the stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,488.18, for a total value of $9,010,929.90. Following the completion of the sale, the insider directly owned 187 shares of the company’s stock, valued at approximately $278,289.66. This represents a 97.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 474 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total transaction of $679,512.18. Following the transaction, the director owned 311 shares in the company, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 19,565 shares of company stock valued at $28,683,737 in the last 90 days. Company insiders own 1.94% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Versant Capital Management Inc raised its holdings in shares of Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the last quarter. SJS Investment Consulting Inc. raised its stake in Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the last quarter. Salomon & Ludwin LLC acquired a new stake in Mettler-Toledo International during the 3rd quarter worth approximately $43,000. Root Financial Partners LLC acquired a new stake in Mettler-Toledo International during the 3rd quarter worth approximately $42,000. Finally, NewSquare Capital LLC grew its stake in shares of Mettler-Toledo International by 94.4% in the 2nd quarter. NewSquare Capital LLC now owns 35 shares of the medical instruments supplier’s stock valued at $41,000 after purchasing an additional 17 shares during the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,404.89 on Friday. The stock has a market cap of $28.70 billion, a PE ratio of 35.03, a P/E/G ratio of 4.18 and a beta of 1.41. The stock’s fifty day moving average is $1,432.93 and its two-hundred day moving average is $1,346.40. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 426.96% and a net margin of 21.20%.The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same quarter in the prior year, the business posted $10.21 EPS. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.